129 related articles for article (PubMed ID: 9723792)
1. Effects of intrastriatal cannabinoids on rotational behavior in rats: interactions with the dopaminergic system.
Sañudo-Peña MC; Force M; Tsou K; Miller AS; Walker JM
Synapse; 1998 Oct; 30(2):221-6. PubMed ID: 9723792
[TBL] [Abstract][Full Text] [Related]
2. Effects of intrapallidal cannabinoids on rotational behavior in rats: interactions with the dopaminergic system.
Sañudo-Peña MC; Walker JM
Synapse; 1998 Jan; 28(1):27-32. PubMed ID: 9414015
[TBL] [Abstract][Full Text] [Related]
3. Effects of intranigral cannabinoids on rotational behavior in rats: interactions with the dopaminergic system.
Sañudo-Peña MC; Patrick SL; Patrick RL; Walker JM
Neurosci Lett; 1996 Mar; 206(1):21-4. PubMed ID: 8848272
[TBL] [Abstract][Full Text] [Related]
4. A vehicle injection into the right core of the nucleus accumbens both reverses the region-specificity and alters the type of contralateral turning elicited by unilateral stimulation of dopamine D2/D3 and D1 receptors in the left core of the nucleus accumbens.
Ikeda H; Kotani A; Koshikawa N; Cools AR
Eur J Pharmacol; 2007 Dec; 577(1-3):64-70. PubMed ID: 17884038
[TBL] [Abstract][Full Text] [Related]
5. Role of the superior colliculus in the motor effects of cannabinoids and dopamine.
Sañudo-Peña MC; Tsou K; Romero J; Mackie K; Walker JM
Brain Res; 2000 Jan; 853(2):207-14. PubMed ID: 10640618
[TBL] [Abstract][Full Text] [Related]
6. Super-stereotypy II: enhancement of a complex movement sequence by intraventricular dopamine D1 agonists.
Berridge KC; Aldridge JW
Synapse; 2000 Sep; 37(3):205-15. PubMed ID: 10881042
[TBL] [Abstract][Full Text] [Related]
7. The cannabinoid agonists WIN 55,212-2 and CP 55,940 attenuate rotational behavior induced by a dopamine D1 but not a D2 agonist in rats with unilateral lesions of the nigrostriatal pathway.
Anderson LA; Anderson JJ; Chase TN; Walters JR
Brain Res; 1995 Sep; 691(1-2):106-14. PubMed ID: 8590042
[TBL] [Abstract][Full Text] [Related]
8. Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists.
Berridge KC; Aldridge JW
Synapse; 2000 Sep; 37(3):194-204. PubMed ID: 10881041
[TBL] [Abstract][Full Text] [Related]
9. Intrastriatal dopamine D1 receptor agonist-mediated motor behavior is reduced by local neurokinin 1 receptor antagonism.
Krolewski DM; Bishop C; Walker PD
Synapse; 2005 Jul; 57(1):1-7. PubMed ID: 15858838
[TBL] [Abstract][Full Text] [Related]
10. Dinapsoline: characterization of a D1 dopamine receptor agonist in a rat model of Parkinson's disease.
Gulwadi AG; Korpinen CD; Mailman RB; Nichols DE; Sit SY; Taber MT
J Pharmacol Exp Ther; 2001 Feb; 296(2):338-44. PubMed ID: 11160615
[TBL] [Abstract][Full Text] [Related]
11. Blockade of globus pallidus adenosine A(2A) receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D(1) or D(2) dopamine receptor agonists.
Simola N; Fenu S; Baraldi PG; Tabrizi MA; Morelli M
Synapse; 2008 May; 62(5):345-51. PubMed ID: 18297692
[TBL] [Abstract][Full Text] [Related]
12. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
Wirtshafter D; Osborn CV
Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
[TBL] [Abstract][Full Text] [Related]
13. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
McPherson RJ; Marshall JF
Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
[TBL] [Abstract][Full Text] [Related]
14. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
Schmidt HD; Pierce RC
Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
[TBL] [Abstract][Full Text] [Related]
15. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
Cauli O; Morelli M
Psychopharmacology (Berl); 2002 Jul; 162(3):246-54. PubMed ID: 12122482
[TBL] [Abstract][Full Text] [Related]
16. Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW 373U86 and SNC 80: 3. Facilitation of D1 and D2 responses in unilaterally 6-hydroxydopamine-lesioned rats.
Pinna A; Di Chiara G
Behav Pharmacol; 1998 Feb; 9(1):15-21. PubMed ID: 9832944
[TBL] [Abstract][Full Text] [Related]
17. D(2), but not D(1) dopamine receptor agonists potentiate cannabinoid-induced sedation in nonhuman primates.
Meschler JP; Clarkson FA; Mathews PJ; Howlett AC; Madras BK
J Pharmacol Exp Ther; 2000 Mar; 292(3):952-9. PubMed ID: 10688609
[TBL] [Abstract][Full Text] [Related]
18. The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors.
Popoli P; Pèzzola A; Torvinen M; Reggio R; Pintor A; Scarchilli L; Fuxe K; Ferré S
Neuropsychopharmacology; 2001 Oct; 25(4):505-13. PubMed ID: 11557164
[TBL] [Abstract][Full Text] [Related]
19. Dopamine receptor regulation of Ca2+ levels in individual isolated nerve terminals from rat striatum: comparison of presynaptic D1-like and D2-like receptors.
Wu J; Dougherty JJ; Nichols RA
J Neurochem; 2006 Jul; 98(2):481-94. PubMed ID: 16805841
[TBL] [Abstract][Full Text] [Related]
20. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
Strömberg I; Kehr J; Andbjer B; Fuxe K
Exp Neurol; 2000 Jul; 164(1):154-65. PubMed ID: 10877926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]